Acadia Healthcare Q4 2023 revenue up 10% to $742.8M; adj. EPS $0.85

Acadia Healthcare Company, Inc.

2023-FY EPS reported -$0.24 revenue$2,928,738,000

Revenue $742.8M (+10.0% YoY); same-facility revenue +10.3%.
Net income $57.7M ($0.63 diluted EPS); adjusted net income $78.3M ($0.85 diluted EPS).
Adjusted EBITDA $169.6M (+11.9% YoY, excluding PRF and prior-year reserve adjustment).
Opened 1 de novo hospital, added 98 beds, opened 2 CTCs during Q4.
Provided FY 2024 and Q1 2024 guidance; announced JV with Ascension Seton in Austin, TX.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Acadia Healthcare Company, Inc. reported financial results for fourth quarter and year ended December 31, 2023.

Period: fourth quarter and year ended December 31, 2023
Result: reported results

Exact text from the filing

On February 27, 2024, Acadia Healthcare Company, Inc. (“Acadia”) issued a press release announcing, among other things, Acadia’s operating and financial results for the fourth quarter and year ended December 31, 2023.

View on SEC.gov

Browse all earnings releases →

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-24-005735

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.